glp 1 medicamentos Del piquete a la pastilla: la revolución de los Fármacos basados en GLP-1: mecanismos

J Am Heart Assoc 12(11):e029282 Labouesse MA, Stadlbauer U, Weber E, Arnold M, Langhans W, Pacheco-Lpez G (2012) Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4

Who Is a Good Candidate for Tirzepatide

Coverage varies widely

These come as once a week self-injection medications

Semaglutide activates (an agonist) the GLP-1 receptor, while tirzepatide is in a new class of dual agonists: it activates (mimics) both the GLP-1 receptor and GIP receptors (Gastric inhibit polypeptide is also known as glucose-dependent insulinotropic polypeptide.) The potency of activation for tirzepatide is 5-fold more for GIPR than GLP1

The choice comes down to side effect tolerance and patient preference